Opdivo-Yervoy (nivolumab-ipilimumab)

pCPA File Number: 20986
Negotiation Status:
Concluded with an LOI
Indication(s):
Metastatic Melanoma
Sponsor/Manufacturer:
Bristol Myers Squibb Canada Inc.
CDA-AMC Project Number:
PC0098-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: